Daniel Wychrij

Daniel Wychrij completed his MSci in Biochemistry at the University of Manchester, during which time he performed research in the laboratory of Dr Ilaria Russo, identifying and profiling inhibitors against Plasmepsin V, a Plasmodium falciparum aspartic protease which is responsible for protein export. After graduation, Daniel moved to Washington University in St Louis as a visiting researcher in the laboratory of Dr Daniel Goldberg. While there, he investigated the mechanism of action of the toxic Plasmodium falciparum protein Histidine-rich protein II (HRPII). Daniel is currently a PhD student in the laboratory of Dr Karen Norris, in the Department of Infectious Diseases and the Center for Vaccines and Immunology. His research is focused on the development of novel vaccine strategies and therapeutics for the prevention and treatment of fungal infections.